Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

Table 4 Univariate analysis for OS rate

	1-year OS rate (%)	2-year OS rate (%)	P Value
Concurrence of metastasis in other sites
Yes	59.4	59.4	0.740
No	57.1	50.0
Systemic therapy after SBRT
Yes	71.4	71.4	0.119
No	41.0	30.8
Local control
Yes	50.4	45.3	0.320
No	100	100
Metastasis in other sites after SBRT
Yes	56.7	52.0	0.164
No	66.7	66.7
Age (years)
<60	56.2	46.9	0.674
≥ 60	58.7	58.7

ISSN: 1748-717X